Use of antidepressants in patients with moderate-to-severe Crohn's disease

被引：0
|
作者：
Lichtenstein, GR
Colombel, JF
Yan, S
Bala, M
Olson, A
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Hop Calmette, Lille, France
[3] Centocor Inc, Malvern, PA 19355 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
773
引用
收藏
页码：S250 / S251
页数：2
相关论文
共 50 条
  • [41] MemantineA pharmacoeconomic review of its use in moderate-to-severe Alzheimer’s disease
    Greg L. Plosker
    Katherine A. Lyseng-Williamson
    PharmacoEconomics, 2005, 23 : 193 - 206
  • [42] Pharmacokinetics of Adalimumab in Pediatric Patients With Moderate to Severe Crohn's Disease
    Eckert, Doerthe
    Mensing, Sven
    Sharma, Shringi
    Thakkar, Roopal
    Robinson, Anne
    Hyams, Jeffrey S.
    Rosh, Joel R.
    Ruemmele, Frank
    Awni, Walid M.
    GASTROENTEROLOGY, 2013, 144 (05) : S228 - S228
  • [43] Memantine - A pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease
    Plosker, GL
    Lyseng-Williamson, KA
    PHARMACOECONOMICS, 2005, 23 (02) : 193 - 206
  • [44] Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasis
    Bissonnette, Robert
    Tamaz, Raja
    Bolduc, Chantal
    Maari, Catherine
    Robillard, Caroline
    Nigen, Simon
    Delorme, Isabelle
    Lynde, Charles
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) : 755 - 756
  • [45] Memantine in moderate-to-severe Alzheimer's disease - Reply
    Reisberg, B
    Doody, R
    Mobius, HJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 610 - 610
  • [46] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
    Howard, Robert
    McShane, Rupert
    Lindesay, James
    Ritchie, Craig
    Baldwin, Ashley
    Barber, Robert
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Jones, Rob
    Jones, Roy
    McKeith, Ian
    Macharouthu, Ajay
    O'Brien, John
    Passmore, Peter
    Sheehan, Bart
    Juszczak, Edmund
    Katona, Cornelius
    Hills, Robert
    Knapp, Martin
    Ballard, Clive
    Brown, Richard
    Banerjee, Sube
    Onions, Caroline
    Griffin, Mary
    Adams, Jessica
    Gray, Richard
    Johnson, Tony
    Bentham, Peter
    Phillips, Patrick
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
  • [47] Biological agents may be better sooner, rather than later, in moderate-to-severe Crohn's disease
    不详
    Drugs & Therapy Perspectives, 2007, 23 (5) : 15 - 18
  • [48] Insurance Companies' Poor Adherence to Guidelines for Moderate-to-Severe Ulcerative Colitis/Crohn's Disease Management
    Anderson, Kelsey L.
    Anand, Rajsavi
    Feuerstein, Joseph D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (07): : 1417 - 1420
  • [49] Pharmacological treatment in moderate-to-severe Alzheimer's disease
    Hsiung, Ging-Yuek Robin
    Feldman, Howard H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) : 2575 - 2582
  • [50] Effectiveness of risankizumab in moderate-to-severe Crohn's Disease: A Canadian multicentric real-world study
    Zoughlami, A.
    Abbas, A.
    Almushir, S.
    Zeghal, M.
    Khan, N. S.
    Milgrom, R.
    Daher, S.
    Mccurdy, J. D.
    Narula, N.
    Rosenfeld, G.
    Silverberg, M. S.
    Lakatos, P. L.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1819 - i1819
12345